AN2 Therapeutics , Inc. (NASDAQ:ANTX), a biopharmaceutical company focused on developing treatments for infectious diseases, ...

Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...

The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

Exo-Top was established under the jurisdiction of the State of Nevada. Basing Exo-Top in the U.S. offers key advantages, including proximity to strategic partners, access to a robust biopharma ...

Roche will continue a careful approach to high-priced deals, putting science at the center of its business development ...

Some you might hold only temporarily, while others you own for decades. David Jagielski (Eli Lilly): A forever stock you can ...

The event will be webcast live and may be accessed via a link in the Investors section of the Nurix website. The archived ...

Chronic Pain, that persists beyond the usual recovery period or occurs along with a chronic health condition, such as arthritis. The rising prevalence of chronic pain drives market growth by ...

Chief R&D and commercial officer Najat Khan, PhD, tells GEN Edge the company aims to improve design of studies, accelerate enrollment, and enhance evidence generation.

The acquisition includes a pipeline of next-generation therapeutic candidates ... The ImaginAb capabilities combined with Telix’s existing investments in new target development, conjugation and ...

FY25 saw AdAlta (ASX:1AD) focus on increasing its corporate muscle, with two new board members and additional advisors ...